Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Annick Hens"'
Autor:
Marie-Christine Bissery, Benedikt Timmerman, Thierry Hercend, Herman Goossens, Nathalie Cools, Viggo Van Tendeloo, Anne Goubier, Christophe Depuydt, Ilse De Coster, Annick Hens, Myriam Bouillette-Marussig, Pierre Van Damme
Purpose: Women infected with human papillomavirus (HPV) with normal cytology to mild abnormalities currently have no treatment options other than watchful waiting or surgery if high-grade cervical lesions or cancer develop. A therapeutic vaccine woul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::825800b940addb8447cb97b4f6932bcf
https://doi.org/10.1158/1078-0432.c.6525011
https://doi.org/10.1158/1078-0432.c.6525011
Autor:
Marie-Christine Bissery, Benedikt Timmerman, Thierry Hercend, Herman Goossens, Nathalie Cools, Viggo Van Tendeloo, Anne Goubier, Christophe Depuydt, Ilse De Coster, Annick Hens, Myriam Bouillette-Marussig, Pierre Van Damme
Worst Cervical cytology during the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::385e3eb132afe24e0945ac9b91ef3cb4
https://doi.org/10.1158/1078-0432.22462127
https://doi.org/10.1158/1078-0432.22462127
Autor:
Marie-Christine Bissery, Benedikt Timmerman, Thierry Hercend, Herman Goossens, Nathalie Cools, Viggo Van Tendeloo, Anne Goubier, Christophe Depuydt, Ilse De Coster, Annick Hens, Myriam Bouillette-Marussig, Pierre Van Damme
Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a655edbcf99717e86e0a6f0829949499
https://doi.org/10.1158/1078-0432.22462133.v1
https://doi.org/10.1158/1078-0432.22462133.v1
Autor:
Marie-Christine Bissery, Benedikt Timmerman, Thierry Hercend, Herman Goossens, Nathalie Cools, Viggo Van Tendeloo, Anne Goubier, Christophe Depuydt, Ilse De Coster, Annick Hens, Myriam Bouillette-Marussig, Pierre Van Damme
Mean background corrected ELISpot magnitudes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9c49d469a866664afd0cd6a1c2759b
https://doi.org/10.1158/1078-0432.22462136
https://doi.org/10.1158/1078-0432.22462136
Autor:
Rajeka Lazarus, Sarah Kelly, Matthew D Snape, Corinne Vandermeulen, Merryn Voysey, Karel Hoppenbrouwers, Annick Hens, Pierre Van Damme, Stephanie Pepin, Isabel Leroux-Roels, Geert Leroux-Roels, Andrew J Pollard
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165384 (2016)
Avian influenza continues to circulate and remains a global health threat not least because of the associated high mortality. In this study antibody persistence, booster vaccine response and cross-clade immune response between two influenza A(H5N1) v
Externí odkaz:
https://doaj.org/article/f532823a7a77430da33c44142002e089
Autor:
Alex Vorsters, Severien Van Keer, Samantha Biesmans, Annick Hens, Ilse De Coster, Herman Goossens, Margareta Ieven, Pierre Van Damme
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 5, p 750 (2016)
The link between infection with high-risk human papillomavirus (hrHPV) and cervical cancer has been clearly demonstrated. Virological end-points showing the absence of persistent HPV infection are now accepted as a way of monitoring the impact of pro
Externí odkaz:
https://doaj.org/article/7776db85405741f689d5ec388b1e57ce
Autor:
Meral Esen, Yves Horsmans, Annick Hens, Fernanda Tavares Da Silva, Nathalie Garçon, Frédéric Clement, Isabelle Carletti, Michel Janssens, Geert Leroux-Roels, Laurence Fissette, Robbert van der Most, Jack Levy, Tino F. Schwarz, Wivine Burny, Pascale Van Belle, Philippe Moris, Arnaud Marchant, Edwige Haelterman, Pierre Van Damme, Peter G. Kremsner, Arnaud M. Didierlaurent, Wolfgang Jilg, Marcelle Van Mechelen, Julian J. Gabor
Publikováno v:
Clinical immunology
Clinical Immunology, Vol. 169, p. 16-27 (2016)
CLINICAL IMMUNOLOGY
Clinical immunology, 169
Clinical Immunology, Vol. 169, p. 16-27 (2016)
CLINICAL IMMUNOLOGY
Clinical immunology, 169
Immunogenicity and safety of different adjuvants combined with a model antigen (HBsAg) were compared. Healthy HBV-naïve adults were randomized to receive HBs adjuvanted with alum or Adjuvant Systems AS01B, AS01E, AS03A or AS04 at Days 0 and 30. Diff
Publikováno v:
Bijblijven. 31:535-554
De wetenschappelijke kennis over vaccins evolueert in hoog tempo, de epidemiologie van infectieziekten verandert voortdurend en nieuwe vaccins verschijnen op de markt. Voor een aantal belangrijke tropenziekten schetst deze bijdrage de bestaande vacci
Autor:
Koen Van Herck, Annick Hens, Pierre Van Damme, Ilse De Coster, André Vertruyen, Jeroen Tolboom, Michal Sarnecki
Publikováno v:
The pediatric infectious disease journal
Background: The pediatric dose of the virosomal hepatitis A vaccine Epaxal (R), Epaxal (R) Junior, is safe and immunogenic in children from 1 to 17 years of age. The present study investigated the long-term immunogenicity of Epaxal (R) Junior. The st
Autor:
Stephanie Pepin, Merryn Voysey, Corinne Vandermeulen, Annick Hens, Sarah Kelly, Isabel Leroux-Roels, Karel Hoppenbrouwers, Pierre Van Damme, Rajeka Lazarus, Andrew J. Pollard, Geert Leroux-Roels, Matthew D. Snape
Publikováno v:
PLOS ONE
PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0165384 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 11, p e0165384 (2016)
© 2016 Lazarus et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d452655fd4626a952bab61e9a646b847
https://hdl.handle.net/1854/LU-8528350
https://hdl.handle.net/1854/LU-8528350